Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	106868
Country	Greece

Received	2025-03-10 05:57
Peer-Review Started	2025-03-10 05:57
To Make the First Decision
Return for Revision	2025-03-19 05:55
Revised	2025-04-01 18:03
Second Decision	2025-07-28 02:37
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-07-28 07:52
Articles in Press	2025-07-28 07:52
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2025-09-02 02:46
Publish the Manuscript Online	2025-09-15 08:37

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Status quo of hypercoagulation as a prognostic indicator following neoadjuvant immunochemotherapy in locally advanced gastric cancer
Manuscript Source	Invited Manuscript
All Author List	Grigorios Christodoulidis, Dimitra Bartzi, Kyriaki Tsagkidou, Konstantinos Eleftherios Koumarelas and Dimitrios Zacharoulis
Funding Agency and Grant Number
Corresponding Author	Grigorios Christodoulidis, MD, PhD, Department of General Surgery, University Hospital of Larissa, Mezourlo, Larissa 41110, Thessalia, Greece. gregsurg@yahoo.gr
Key Words	Indicator; Hypercoagulation; Biomarker; Gastric cancer; Immunochemotherapy
Core Tip	The core message of the review emphasizes that hypercoagulation, observed after neoadjuvant immunochemotherapy in patients with locally advanced gastric cancer, serves as a significant independent prognostic indicator. Elevated coagulation markers such as D-dimer and fibrinogen are associated with poorer overall and disease-free survival rates. The article suggests that monitoring these coagulation parameters can enhance patient management by identifying high-risk individuals and tailoring postoperative care accordingly.
Publish Date	2025-09-15 08:37
Citation	<p>Christodoulidis G, Bartzi D, Tsagkidou K, Koumarelas KE, Zacharoulis D. Status quo of hypercoagulation as a prognostic indicator following neoadjuvant immunochemotherapy in locally advanced gastric cancer. <i>World J Gastrointest Oncol</i> 2025; 17(9): 106868</p>
URL	https://www.wjgnet.com/1948-5204/full/v17/i9/106868.htm
DOI	https://dx.doi.org/10.4251/wjgo.v17.i9.106868

Full Article (PDF)	WJGO-17-106868-with-cover.pdf
Manuscript File	106868_Auto_Edited_080034.docx
Answering Reviewers	106868-answering-reviewers.pdf
Audio Core Tip	106868-audio.mp3
Conflict-of-Interest Disclosure Form	106868-conflict-of-interest-statement.pdf
Copyright License Agreement	106868-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	106868-non-native-speakers.pdf
Peer-review Report	106868-peer-reviews.pdf
Scientific Misconduct Check	106868-scientific-misconduct-check.png
Scientific Editor Work List	106868-scientific-editor-work-list.pdf
CrossCheck Report	106868-crosscheck-report.pdf